Patents by Inventor Warren W. Wakarchuk

Warren W. Wakarchuk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7608442
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: October 11, 2006
    Date of Patent: October 27, 2009
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Publication number: 20090215115
    Abstract: The present invention provides, e.g., sialyltransferase proteins comprising conserved sequence motifs, including ?-2,3-sialyltransferase proteins from C. jejuni strains O:36 and O:19. The invention also provides methods of making sialylated products using those sialyltransferases.
    Type: Application
    Filed: September 16, 2005
    Publication date: August 27, 2009
    Applicant: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W.. Wakarchuk
  • Patent number: 7462474
    Abstract: This invention provides prokaryotic ?1,4-N-acetylgalactosaminyl (GalNAc) transferases involved in synthesis of lipooligosaccharide (LOS). ?1,4-GalNAc transferases are obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the ?1,4-GalNAc transferases, as well as expression vectors and host cells for expressing the ?1,4-GalNAc transferases.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: December 9, 2008
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7384771
    Abstract: This invention provides prokaryotic ?1,4-N-acetylgucosaminyl (GalNAc) transferases involved in synthesis of lipooligosaccharide (LOS). The ?1,4-GalNAc transferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the ?1,4-GalNAc transferases, as well as expression vectors and host cells for expressing the ?1,4-GalNAc transferases.
    Type: Grant
    Filed: April 23, 2004
    Date of Patent: June 10, 2008
    Assignee: National Research of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7381544
    Abstract: This invention provides fusion polypeptides that include a glycosyltransferase catalytic domain and a catalytic domain from an accessory enzyme that is involved in making a substrate for a glycosyltransferase reaction. Nucleic acids that encode the fusion polypeptides are also provided, as are host cells for expressing the fusion polypeptides of the invention.
    Type: Grant
    Filed: December 11, 2002
    Date of Patent: June 3, 2008
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, N. Martin Young, Warren W. Wakarchuk
  • Patent number: 7371838
    Abstract: This invention provides prokaryotic ?1,4-N-acetylglucosaminyl (GalNAc) traosferases involved in synthesis of lipooligosaccharide (LOS). The ?1,4-GalNAc transferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the ?1,4-GaINAc transferases, as well as expression vectors and host cells for expressing the ?1,4-GalNAc transferases.
    Type: Grant
    Filed: April 22, 2004
    Date of Patent: May 13, 2008
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7259239
    Abstract: The structure and specificity of a recombinant ?2,3-sialyltransferase from Campylobacter spp., is disclosed. Also provided are methods for using the ?2,3-sialyltransferase in the production of desired carbohydrate structures and nucleic acids that encode the sialyltransferase.
    Type: Grant
    Filed: March 11, 2004
    Date of Patent: August 21, 2007
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7244601
    Abstract: This invention provides fusion polypeptides that include a glycosyltransferase catalytic domain and a catalytic domain from an accessory enzyme that is involved in making a substrate for a glycosyltransferase reaction. Nucleic acids that encode the fusion polypeptides are also provided, as are host cells for expressing the fusion polypeptides of the invention.
    Type: Grant
    Filed: December 14, 1998
    Date of Patent: July 17, 2007
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, N. Martin Young, Warren W. Wakarchuk
  • Patent number: 7238509
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: July 3, 2007
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7220848
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: May 22, 2007
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7217549
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: May 21, 2004
    Date of Patent: May 15, 2007
    Assignee: National Research Council of Cananda
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7211657
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: April 7, 2004
    Date of Patent: May 1, 2007
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7208304
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: May 17, 2004
    Date of Patent: April 24, 2007
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7202353
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: April 10, 2007
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7192756
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: March 20, 2007
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7189836
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: March 13, 2007
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7169914
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: December 11, 2003
    Date of Patent: January 30, 2007
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7169593
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: May 12, 2004
    Date of Patent: January 30, 2007
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7166717
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: May 12, 2004
    Date of Patent: January 23, 2007
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk
  • Patent number: 7138258
    Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ?2,3- and an ?2,8-activity. A ?1,4-GalNAc transferase and a ?1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example, Campylobacter species, including C. jejuni. In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: November 21, 2006
    Assignee: National Research Council of Canada
    Inventors: Michel Gilbert, Warren W. Wakarchuk